Business Context and Reporting Period
Company: Bruker Biosciences Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2004
Reporting Period: Third quarter and nine months ended September 30, 2004
This filing serves to announce the issuance of a press release containing financial results for the specified periods. The detailed financial data is contained within Exhibit 99.1 (Press Release dated November 3, 2004), which is furnished but not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The Form 8-K text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained in the attached press release (Exhibit 99.1), the content of which is not included in the provided source text.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the body of the 8-K. It directs readers to the attached press release for the announcement of results for the third quarter and nine months ended September 30, 2004.
Guidance, Outlook, and Risks
Management Commentary: The report confirms the issuance of a press release by the company on November 3, 2004.
Legal Status of Information: The information in this report and Exhibit 99.1 is furnished and shall not be deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It shall not be incorporated by reference into any filing under the Securities Act of 1933 unless expressly set forth by specific reference.
Risks and Contingencies: No specific risks or contingencies are detailed in the 8-K text provided.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the third quarter and nine months ended September 30, 2004, by reviewing the attached Exhibit 99.1 (Press Release).
- Confirm whether the press release includes updated forward-looking guidance or outlook statements.
- Note that the financial data in this filing is not subject to the liabilities of Section 18 of the Securities Exchange Act of 1934 as it is furnished rather than filed.
- Check subsequent filings to see if the information in Exhibit 99.1 has been incorporated by reference into other SEC documents.